Evecxia Therapeutics
Raleigh
About Evecxia Therapeutics
Evecxia Therapeutics is a pharmaceutical company that develops drugs to help patients suffering from disabling neuropsychiatric conditions. It aims to develop and commercialize EVX-101 to treat patients suffering from disabling, common, and costly neuropsychiatric conditions for which current therapies are inadequate, in particular depression. The company was established in 2013 and is based in Raleigh, North Carolina.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: Less than $1M
- Total funding: $20.1M
- Funding stage: Early Stage Venture
- Last round: Series A (Sep 2025)
- Website: evecxia.com
- Phone: [email protected]
Industries & Categories
Health Care, Pharmaceutical, Therapeutics
Canonical: https://fsome.com/organization/evecxia-therapeutics-31596 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.